Clicky

Hangzhou Tigermed Consulting Co Ltd(3347)

Description: Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.


Keywords: Project Management Data Management Technology Services Medical Imaging Clinical Trial Clinical Research Clinical Services In Vitro Diagnostics Site Management Contract Research Organization Manufacturing Practice Pharmacovigilance Biometrics Services Contract Research Organization Services Good Manufacturing Practice Dokumeds Draft:Titansmedical Party Audit Trial Services Trial System Solution

Home Page: www.tigermed.net

F18, Building A – Shengda Science Park
Hangzhou, 310051
China
Phone: 86 57 1288 87227


Officers

Name Title
Dr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D. Founder & Chairman
Dr. Xiaochun Cao M.D. Co-Founder, Pres, GM & Exec. Director
Mr. Hao Wu Co-Pres & Exec. Director
Ms. Zhuan Yin M.D. Exec. VP & Exec. Director
Ms. Chengcheng Yang Chief Financial Officer
Mr. Zengyu Wen Exec. VP & COO
Dr. Tianrong Ji M.D., Ph.D. Chief Investment Officer
Mr. Guoyun Yu Head of Accounting Department
Mr. Jiansong Yang Ph.D. Sr. VP & Chief Scientific Officer
Mr. Qing Li VP of HR & Field Service

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 25
Trailing PE: 27.4859
Price-to-Book MRQ: 3.0882
Price-to-Sales TTM: 11.8901
IPO Date:
Fiscal Year End: December
Full Time Employees: 8326
Back to stocks